(Q73523907)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11213099%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11213099%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

main subject

hepatocellular carcinoma

1 reference

1 reference

1 reference

S Nishiguchi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11213099%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S Shiomi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11213099%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S Nakatani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11213099%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

T Takeda

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11213099%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

K Fukuda

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11213099%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A Tamori

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11213099%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

D Habu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11213099%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

T Tanaka

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11213099%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11213099%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11213099%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

357

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11213099%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

196-197

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11213099%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

9251

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11213099%20AND%20SRC:MED&resulttype=core&format=json

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903595-9

7 January 2021

The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903595-9

7 January 2021

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903595-9

7 January 2021

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903595-9

7 January 2021

10.1016/S0140-6736(00)03595-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11213099%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference